Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 30, 2021	Oct. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ 46,804	$ (59,462)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Amortization and write-off of deferred debt issuance costs	1,161	108
Impairment of assets	(2,103)	15,200
Depreciation and amortization	13,031	16,374
Stock compensation expense	938	1,123
Board of directors stock compensation	296	269
Changes in operating assets and liabilities:
Accounts receivable	4,812	997
Inventories	2,744	7,522
Prepaid expenses and other current assets	(3,237)	5,348
Other assets	360	675
Accounts payable	2,674	(3,183)
Operating leases, net	(12,275)	763
Accrued expenses and other liabilities	8,945	5,631
Net cash provided by (used for) operating activities	64,150	(8,635)
Cash flows from investing activities:
Additions to property and equipment, net	(2,802)	(2,938)
Net cash used for investing activities	(2,802)	(2,938)
Cash flows from financing activities:
Proceeds from issuance of common stock from private direct offering, net of offering costs	4,375
Net borrowings (repayments) under credit facility	(59,733)	28,677
Debt extinguishment costs	(1,111)
Debt issuance costs	(1,143)	(25)
Tax withholdings paid related to net share settlements	(1,146)
Proceeds from the exercise of stock options	350
Net cash provided by (used for) financing activities	(73,408)	28,652
Net increase (decrease) in cash and cash equivalents	(12,060)	17,079
Cash and cash equivalents:
Beginning of period	18,997	4,338
End of period	6,937	$ 21,417
FILO Loan
Cash flows from financing activities:
Repayment of FILO loans	(32,500)
Proceeds from new FILO loan	$ 17,500